These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 30416686)
41. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients. Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008 [TBL] [Abstract][Full Text] [Related]
42. Molecular Biomarkers for Early Detection and Prevention of Ovarian Cancer-A Gateway for Good Prognosis: A Narrative Review. Yadav G; Vashisht M; Yadav V; Shyam R Int J Prev Med; 2020; 11():135. PubMed ID: 33088463 [TBL] [Abstract][Full Text] [Related]
43. Ovarian cancer biomarkers: a focus on genomic and proteomic findings. Tinelli A; Vergara D; Martignago R; Leo G; Malvasi A; Tinelli R; Marsigliante S; Maffia M; Lorusso V Curr Genomics; 2007 Aug; 8(5):335-42. PubMed ID: 19384429 [TBL] [Abstract][Full Text] [Related]
44. Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma. Ezzati M; Abdullah A; Shariftabrizi A; Hou J; Kopf M; Stedman JK; Samuelson R; Shahabi S Int Sch Res Notices; 2014; 2014():953509. PubMed ID: 27382614 [TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas. Engqvist H; Parris TZ; Kovács A; Nemes S; Werner Rönnerman E; De Lara S; Biermann J; Sundfeldt K; Karlsson P; Helou K BMC Cancer; 2019 Sep; 19(1):928. PubMed ID: 31533654 [TBL] [Abstract][Full Text] [Related]
48. Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial. Forlani L; De Cecco L; Simeon V; Paolini B; Bagnoli M; Cecere SC; Spina A; Citeroni E; Bignotti E; Lorusso D; Arenare L; Russo D; De Angelis C; Ardighieri L; Scognamiglio G; Del Sesto M; Tognon G; Califano D; Schettino C; Chiodini P; Perrone F; Mezzanzanica D; Pignata S; Tomassetti A J Exp Clin Cancer Res; 2023 Apr; 42(1):83. PubMed ID: 37041632 [TBL] [Abstract][Full Text] [Related]
49. Metabolic Alterations and WNT Signaling Impact Immune Response in HGSOC. Arend RC; Scalise CB; Gordon ER; Davis AM; Foxall ME; Johnston BE; Crossman DK; Cooper SJ Clin Cancer Res; 2022 Apr; 28(7):1433-1445. PubMed ID: 35031546 [TBL] [Abstract][Full Text] [Related]
50. Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary? Hu Y; Taylor-Harding B; Raz Y; Haro M; Recouvreux MS; Taylan E; Lester J; Millstein J; Walts AE; Karlan BY; Orsulic S Front Cell Dev Biol; 2020; 8():647. PubMed ID: 32766252 [TBL] [Abstract][Full Text] [Related]
51. Assignment of human elongation factor 1alpha genes: EEF1A maps to chromosome 6q14 and EEF1A2 to 20q13.3. Lund A; Knudsen SM; Vissing H; Clark B; Tommerup N Genomics; 1996 Sep; 36(2):359-61. PubMed ID: 8812466 [TBL] [Abstract][Full Text] [Related]
52. The complete amino acid sequence of human muscle glyceraldehyde 3-phosphate dehydrogenase. Nowak K; Wolny M; Banaś T FEBS Lett; 1981 Nov; 134(2):143-6. PubMed ID: 7030790 [No Abstract] [Full Text] [Related]
53. The primary structure of the alpha subunit of human elongation factor 1. Structural aspects of guanine-nucleotide-binding sites. Brands JH; Maassen JA; van Hemert FJ; Amons R; Möller W Eur J Biochem; 1986 Feb; 155(1):167-71. PubMed ID: 3512269 [TBL] [Abstract][Full Text] [Related]
54. Challenges in anti-aging medicine-trends in biomarker discovery and therapeutic interventions for a healthy lifespan. Popescu I; Deelen J; Illario M; Adams J J Cell Mol Med; 2023 Sep; 27(18):2643-2650. PubMed ID: 37610311 [TBL] [Abstract][Full Text] [Related]